The burden of inflammatory bowel disease (IBD) in Asia has been increasing over the past
decades. Although patients with IBD show heterogenous phenotypes depending on the …

Methods A multicenter, cross-sectional, prospective registry was established across four
geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn's disease …

Background Inflammatory bowel disease (IBD) is a chronic inflammatory condition involving
individuals across all age groups. Recent data suggests the increase in the prevalence of …

Background Patients with inflammatory bowel disease (IBD) are at greater risk for
Clostridioides difficile infection (CDI). There remain controversial issues about the …

Background Recently, the role of endogenous microbiota and the genotype-microbiota
correlation in inflammatory bowel disease (IBD) pathogenesis have been highlighted …

Patients with very early-onset inflammatory bowel disease (VEO-IBD) may present because
of underlying monogenic inborn errors of immunity (IEI). Strong differences have been …

Introduction: Immunomodulators remain fundamental for the medical treatment of Crohn's
disease (CD). Methotrexate (MTX) is widely used as a second-line immunomodulator; …

Background: Most data on the effect of Inflammatory bowel disease (IBD) and its treatments
on coronavirus disease 2019 (COVID-19) outcomes have not had non-IBD comparators …

BACKGROUND The COVID-19 pandemic has affected the health care infrastructure
dramatically, with abundant resources necessarily being redirected to COVID-19 patients …

Background/Aims: Although balloon-assisted enteroscopy (BAE) enables endoscopic
visualization of small bowel (SB) involvement in Crohn's disease (CD), there is no data on …